Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

A model for the analysis of nonviral gene therapy

Abstract

Further understanding of the mechanisms involved in cellular and intracellular delivery of transgene is needed to produce clinical applications of gene therapy. The compartmental and computational model designed in this work is integrated with data from previous experiments to quantitatively estimate rate constants of plasmid translocation across cellular barriers in transgene delivery in vitro. The experimental conditions between two cellular studies were held constant, varying only the cell type, to investigate how the rates differed between cell lines. Two rate constants were estimated per barrier for active transport and passive diffusion. Translocation rates of intact plasmid across the cytoplasmic and nuclear barriers varied between cell lines. CV1 cells were defined by slower rates (0.23 h−1 cytoplasmic, 0.08 h–1 nuclear) than those of the HeLa cells (1.87 h−1 cytoplasmic, 0.45 h−1 nuclear). The nuclear envelope was identified as a rate-limiting barrier by comparing the rate of intact plasmid translocation at each barrier. Slower intact plasmid translocation in CV1 cells was correlated with a reduced absolute capacity for transgene efficiency in comparison with HeLa cells. HeLa cells were three times more efficient than CV1 cells at producing green fluorescent protein per intact plasmid delivered to the nucleus. Mathematical modeling coordinated with experimental studies can provide detailed, quantitative understanding of nonviral gene therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Phillips AJ . The challenge of gene therapy and DNA delivery. J Pharm Pharmacol 2000; 53: 1169–1174.

    Article  Google Scholar 

  2. Leopold PL . Fluorescence methods reveal intracellular trafficking of gene transfer vectors: the light toward the end of the tunnel. Mol Ther 2000; 1: 302–303.

    Article  CAS  Google Scholar 

  3. Schatzlein AG . Nonviral vectors in cancer gene therapy: principles and progress. Anticancer Drugs 2001; 12: 275–304.

    Article  CAS  Google Scholar 

  4. Escrious V et al. Cationic lipid-mediated gene transfer: analysis of cellular uptake and nuclear import of plasmid DNA. Cell Biol Toxicol 1997; 14: 95–104.

    Article  Google Scholar 

  5. Lechardeur D et al. Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Therapy 1999; 6: 482–497.

    Article  CAS  Google Scholar 

  6. Capecchi MR . High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 1980; 22: 479–488.

    Article  CAS  Google Scholar 

  7. Boussif O et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethyleneimine. Proc Natl Acad Sci 1995; 92: 7297–7301.

    Article  CAS  Google Scholar 

  8. Farhood H, Serbina N, Huang L . The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta 1995; 1235: 289–295.

    Article  Google Scholar 

  9. Rakhmilevich AL et al. Cytokine gene therapy of cancer using gene gun technology: superior antitumor activity of interleukin-12. Hum Gene Ther 1997; 8: 1303–1311.

    Article  CAS  Google Scholar 

  10. Canatella PJ, Prausnitz MR . Prediction and optimization of gene transfection and drug delivery by electroporation. Gene Therapy 2001; 8: 1464–1469.

    Article  CAS  Google Scholar 

  11. Taniyama Y et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Therapy 2002; 9: 372–380.

    Article  CAS  Google Scholar 

  12. Liu F, Song YK, Liu D . Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy 1999; 6: 1258–1266.

    Article  CAS  Google Scholar 

  13. Cartier R et al. In vivo gene transfer by low-volume jet injection. Anal Biochem 2000; 282: 262–265.

    Article  CAS  Google Scholar 

  14. Pouton CW, Seymour LW . Key issues in non-viral gene delivery. Adv Drug Deliv Rev 1998; 34: 3–19.

    Article  CAS  Google Scholar 

  15. Plank C, Zauner W, Wagner E . Application of membrane-active peptides for drug and gene delivery across cellular membranes. Adv Drug Deliv Rev 1998; 134: 21–35.

    Article  Google Scholar 

  16. Fajac I, Briand P, Monsigny M, Midoux P . Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells. Hum Gene Ther 1999; 10: 395–406.

    Article  CAS  Google Scholar 

  17. Zabner J et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995; 270: 18997–19007.

    Article  CAS  Google Scholar 

  18. Brunner S et al. Cell cycle dependence of gene transfer by lipoplex, polyplexes and recombinant adenovirus. Gene Therapy 2000; 7: 401–407.

    Article  CAS  Google Scholar 

  19. Tseng W-C, Haselton FR, Giorgio TD . Mitosis enhances transgene expression of plasmid delivered by cationic liposomes. Biochim Biophys Acta 1999; 1445: 53–64.

    Article  CAS  Google Scholar 

  20. Ledley TS, Ledley FD . Multicompartment, numerical model of cellular events in the pharmacokinetics of gene therapies. Hum Gene Ther 1994; 5: 679–691.

    Article  CAS  Google Scholar 

  21. Varga CM, Hong K, Lauffenburger DA . Quantitative analysis of synthetic gene delivery vector design properties. Mol Ther 2001; 4: 438–446.

    Article  CAS  Google Scholar 

  22. James MB, Giorgio TD . Nuclear-associated plasmid, but not cell-associated plasmid, is correlated with transgene expression in cultured mammalian cells. Mol Ther 2000; 1: 339–346.

    Article  CAS  Google Scholar 

  23. Chan CK, Jans DA . Using nuclear targeting signals to enhance nonviral gene transfer. Immunol Cell Biol 2002; 80: 119–130.

    Article  CAS  Google Scholar 

  24. Nakanishi M et al. Nuclear targeting of DNA. Eur J Pharm Sci 2001; 13: 17–24.

    Article  CAS  Google Scholar 

  25. Panté N, Kann M . Nuclear pore complex is able to transport macromolecules with diameters of 39 nm. Mol Biol Cell 2002; 13: 425–434.

    Article  Google Scholar 

  26. Stewart M . Nuclear pore structure and function. Semin Cell Biol 1992; 3: 267–277.

    Article  CAS  Google Scholar 

  27. Welz C et al. Nuclear transport of oligonucleotides in HepG2-cells mediated by protamine sulfate and negatively charged liposomes. Pharm Res 2000; 17: 1206–1211.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Bioengineering and Environmental Systems Division of the National Science Foundation under Award BES-9902697. We would also like to acknowledge MB James for use of her experimental data on nonviral gene delivery and Dr MI Miga for reviewing this work.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Banks, G., Roselli, R., Chen, R. et al. A model for the analysis of nonviral gene therapy. Gene Ther 10, 1766–1775 (2003). https://doi.org/10.1038/sj.gt.3302076

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302076

Keywords

This article is cited by

Search

Quick links